Enanta Pharmaceuticals
ENTA
#7572
Rank
NZ$0.63 B
Marketcap
NZ$21.92
Share price
-3.39%
Change (1 day)
109.34%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2025 (TTM): NZ-$6.63

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.55. In 2024 the company made an earnings per share (EPS) of NZ-$8.46.

EPS history for Enanta Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.63-21.71%
2024NZ-$8.46
2021NZ-$8.5272.92%
2020NZ-$4.93-267.44%
2019NZ$2.94-61.35%
2018NZ$7.61147.22%
2017NZ$3.08-460%
2016NZ-$0.86-114.88%
2015NZ$5.75-23.81%
2014NZ$7.54-244.12%
2013NZ-$5.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.05-390.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.59-292.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$4.09-162.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.51-474.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.50-290.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.08-177.55%๐Ÿ‡บ๐Ÿ‡ธ USA